World Gold Medal for Advanced Bone Tissue Scaffolding at ITE 2025 London
Iranian scientists have once again shone on the global stage. Iranian researchers and inventors succeeded in winning the Global Gold Medal and Special Award at the International Inventions and Technology Exhibition (ITE 2025 – London) in the field of dentistry (implants, nanocomposites, and biomaterials) and pharmaceuticals.
Their awarded invention was titled: Development and Optimization of Chitosan-Based Nanocomposite Scaffold Reinforced with Magnesium-Doped Hydroxyapatite and Bioactive Agents (Icariin, lithium Chloride and Naringin) for Bone Tissue Regeneration.The event was held from 22–25 October 2025 (corresponding to 30 Mehr – 2 Aban 1404) at Kingston University, London, UK.The Innovative Team Consisted of:Dr. Sahar Hefzollesan – Project Director: Inventor and researcher in biomaterials, tissue engineering, restorative dentistry, and nanocomposites; holder of a Doctor of Dental Surgery (DDS) and a PhD in Dental Materials from Azerbaijan Medical University; specialist in dental prosthetics and implants; Head of the Dentistry Department at Medera Specialized and Subspecialty Hospital in Azerbaijan.
Dr. Hamed Aghazadeh – Inventor and researcher in cancer biology, stem cells, drug delivery systems, and pharmaceutical formulation; microbiologist; MSc in Pharmaceutical Engineering (M.Pharm.Eng) from the University of Tehran; and Doctor of Pharmacy (Pharm.D) candidate.
Dr. Sahra Hefzollesan – Inventor and researcher in biomaterials, tissue engineering, restorative dentistry, and nanocomposites; Doctor of Dental Surgery (DDS) from Karadeniz Technical University in Turkey.
Dr. Reyhaneh Nasr Azadani – Inventor and researcher in cancer, tissue engineering, and regenerative medicine; holds two Master’s degrees in Biomedical Engineering (Bioelectric and Biomaterials) from Isfahan University of Medical Sciences; PhD candidate in Biomedical Engineering. She has received numerous national and international innovation awards, including the Nuremberg Innovation Award (Germany), Special Award and Gold Medal at the 50th Geneva International Exhibition of Inventions 2025, and gold medals from innovation competitions in Turkey and Saudi Arabia. She has published dozens of scientific papers and registered several patents and international books in medicine, cancer research, and regenerative medicine.
Prof. Fariborz Sharifian Jazi – Full Professor and faculty member at the University of Georgia (Georgia, Europe); ranked among the world’s top 2% scientists; Head of the Nanomaterials Laboratory at the University of Georgia; Editor-in-Chief and owner of the International Journal of Composites and Compounds; inventor and researcher in biomaterials, nanotechnology, and materials engineering; Scientific Secretary of IMIC-2015 (SEM International Competition) and a member of the Materials Research Society (MRS) and the American Chemical Society (ACS).
Dr. Vahid Zare – Neurosurgeon and spine surgeon with a specialty board from Iran University of Medical Sciences; MD from Jundishapur University of Medical Sciences in Ahvaz; neurosurgery residency at Shiraz University of Medical Sciences; advanced fellowship training in neurosurgery and spine surgery at Iran University of Medical Sciences; neurosurgeon in hospitals in Shiraz and Tehran; inventor and researcher in neurosciences with numerous publications on brain tumors—especially glioblastoma multiforme (GBM)—invasive patterns, surgical techniques, and prognosis, as well as spine surgeries, hemorrhage control methods, and hemostasis in neurological operations.
With the presentation of a novel invention in dentistry (implants, nanocomposites, and biomaterials) and pharmaceuticals titled: Development and Optimization of Chitosan-Based Nanocomposite Scaffold Reinforced with Magnesium-Doped Hydroxyapatite and Bioactive Agents (Icariin, lithium Chloride and Naringin) for Bone Tissue Regeneration.the team earned the Gold Medal and Special Award at the ITE 2025 International & Specialized Exhibition (London).dr. Hamed Aghazadeh, CEO of NoyanGen Biotechnology Research Company and one of the inventors, explained: The ITE 2025 International Invention and Innovation Exhibition in England was held from 22 to 25 October 2025 at Kingston University London, organized by leading British academic institutions including Kingston University, the World Invention Intellectual Property Association (WIIPA) and the World Intellectual Property Organization (WIPO).He added: In this global event, participants from 31 countries—including the United States, Brazil, Canada, Turkey, UAE, Saudi Arabia, Lebanon, Iraq, Iran, Afghanistan, Indonesia, and others—presented over 350 innovative inventions and research projects across engineering, medicine, pharmacy, AI, technology, energy, environmental protection, safety, and industry. The diverse participation highlighted the truly international nature of the festival and the connection between East and West at Kingston University London.
The event was visited by UK scientific and governmental officials, as well as the Mayor of Kingston.He continued: The inventions were evaluated by a multidisciplinary international jury consisting of university professors, technologists, intellectual property experts, and industry leaders. The judging process was precise, transparent, and fair. Among more than 350 inventions from 31 countries, we achieved first place globally in the field of medicine and pharmaceuticals.Dr. Sahar Hefzollesan described the innovation:This invention introduces a novel nano-composite scaffold based on chitosan enhanced with magnesium-doped hydroxyapatite (Mg-HAp) and bioactive molecules—icariin, lithium chloride, and naringenin—to improve osteogenesis. The scaffold aims to mimic the extracellular matrix (ECM) of bone, providing mechanical support, osteoinduction, osteoconduction, and angiogenesis.The primary objective is to develop and optimize a chitosan-based nano-composite scaffold containing Mg-HAp and the mentioned bioactive components to enhance bone formation. Using advanced fabrication techniques and targeted improvements, this study seeks to improve the quality and quantity of regenerated bone, offering a sustainable alternative to conventional grafts.Ultimately, the scaffold’s effectiveness will be validated through both in vitro and in vivo studies for potential clinical applications in maxillofacial surgery and orthopedics.#International_Invention_Competition_ITE_2025_London
17:23 - 17 آذر 1404
2 واکنش
405 بازدید
